Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Candel Therapeutics Inc.

    NASDAQ: CADL · Real-Time Price · USD
    6.04
    0.49 (8.83%)
    At close: Jun 06, 2025, 3:59 PM
    6.00
    -0.66%
    Pre-market: Jun 09, 2025, 07:01 AM EDT

    Candel Therapeutics Statistics

    Share Statistics

    Candel Therapeutics has 50.1M shares outstanding. The number of shares has increased by 58.74% in one year.

    Shares Outstanding

    n/a
    		 50.1M

    Shares Change (YoY)

    n/a
    		 58.74%

    Shares Change (QoQ)

    n/a
    		 6.21%

    Owned by Institutions (%)

    n/a
    		 56%

    Shares Floating

    n/a
    		 36.44M

    Failed to Deliver (FTD) Shares

    n/a
    		 88

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 6.22M, so 12.41% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 6.22M

    Short % of Shares Out

    n/a
    		 12.41%

    Short % of Float

    n/a
    		 16.08%

    Short Ratio (days to cover)

    n/a
    		 7.21

    Valuation Ratios

    The PE ratio is -4.98 and the forward PE ratio is -4.32. Candel Therapeutics's PEG ratio is -0.15.

    PE Ratio

    n/a
    		 -4.98

    Forward PE

    n/a
    		 -4.32

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.4

    PB Ratio

    n/a
    		 4.15

    P/FCF Ratio

    n/a
    		 -10.17

    PEG Ratio

    n/a
    		 -0.15
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Candel Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 2.77, with a Debt / Equity ratio of 0.2.

    Current Ratio

    n/a
    		 2.77

    Quick Ratio

    n/a
    		 2.77

    Debt / Equity

    n/a
    		 0.2

    Debt / EBITDA

    n/a
    		 -0.26

    Debt / FCF

    n/a
    		 -0.5

    Interest Coverage

    n/a
    		 -15.97

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,452,026.32

    Employee Count

    n/a
    		 38

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -15.52% in the last 52 weeks. The beta is -0.87, so Candel Therapeutics's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.87

    52-Week Price Change

    n/a
    		 -15.52%

    50-Day Moving Average

    n/a
    		 5.22

    200-Day Moving Average

    n/a
    		 6.5

    Relative Strength Index (RSI)

    n/a
    		 59.13

    Average Volume (20 Days)

    n/a
    		 993,771

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -33.37M

    Net Income

    n/a
    		 -55.18M

    EBITDA

    n/a
    		 -52.1M

    EBIT

    n/a
    		 -53.09M

    Earnings Per Share (EPS)

    n/a
    		 -1.74
    Full Income Statement

    Balance Sheet

    The company has 102.65M in cash and 13.47M in debt, giving a net cash position of 89.18M.

    Cash & Cash Equivalents

    n/a
    		 102.65M

    Total Debt

    n/a
    		 13.47M

    Net Cash

    n/a
    		 89.18M

    Retained Earnings

    n/a
    		 -192.21M

    Total Assets

    n/a
    		 95.91M

    Working Capital

    n/a
    		 73.08M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -27.02M and capital expenditures -16K, giving a free cash flow of -27.04M.

    Operating Cash Flow

    n/a
    		 -27.02M

    Capital Expenditures

    n/a
    		 -16K

    Free Cash Flow

    n/a
    		 -27.04M

    FCF Per Share

    n/a
    		 -0.85
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    CADL does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for CADL is $22, which is 264.2% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $22

    Price Target Difference

    n/a
    		 264.2%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 4
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 4.78

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist